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Abstract
Purpose The purpose of this study is to evaluate the results
of silicone oil removal (SOR) in post-cytomegalovirus
(CMV) retinitis-related retinal detachment in Indian eyes.
Methods A retrospective review of CMV retinitis-related
retinal detachment following SOR was conducted.
Results Out of 60 eyes (55 patients) that had vitrectomy
with silicone oil tamponade between 1995 and 2010, 11
eyes underwent SOR. There were two females and eight
males, and the mean age was 41.27±9.8 years. The duration
between primary detachment surgery and SOR was 8.82±
2.56 months. The mean duration of HIV positivity was 33±
28.65 months (nearly 3 years). The average CD4 cell count
at the time of SOR was 365±85 cells/mm3. The mean best
corrected pre-SOR visual acuity in logMAR was 1±0.85,
and the post-SOR acuity was 1.13±0.67 (p=0.69). The
mean follow-up post-SOR was 7.54±7.76 months. Out of
the 11 eyes that underwent SOR, in 9 eyes, the retina was
attached at the last follow-up. The anatomical success rate
following SOR was 81.82% (9/11; CI, 59.03–100%).
Conclusion The results of this study suggest a relatively low
redetachment rate following SOR in CMV retinitis-related
retinal detachment.
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Introduction
Cytomegalovirus (CMV) retinitis is a well-recognized cause
of retinal detachment in immunocompromised patients with
acquired immunodeficiency syndrome (AIDS). Retinal
detachments in these cases occur due to necrotic breaks at
the junction of healed retinitis and normal retina. As the
breaks are usually multiple, irregular, in thin retina, and
difficult to visualize, primary vitrectomy with long-term
endotamponade with silicone oil is the preferred modality
of management in these detachments [1–4]. Though good
efficacy of gas tamponade with an encircling scleral buckle
has been shown in a previous study with almost 83% suc-
cess rate, the total cohort was very small (six eyes). Primary
vitrectomy still remains the treatment option of choice [5,
6]. Due to the inherent drawbacks of silicone oil in situ like
hyperopic shift and cataractogenesis, silicone oil removal
(SOR) is desirous in these cases at an optimal time [7, 8].
Though safety of silicone oil removal in post-CMV retinitis-
related retinal detachment surgeries has been described be-
fore, the literature on this subset of cases is scarce [9, 10].
The purpose of this article is to assess the outcome of
silicone oil removal in cases of CMV retinitis-related retinal
detachment that were repaired by vitrectomy with silicone
oil tamponade.
Materials and methods
This study was a retrospective noncomparative interven-
tional case series. The records of patients with CMV
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retinitis-related retinal detachment that underwent pars plana
vitrectomy with silicone oil injection at a tertiary eye care
institute in south India between January 1995 and October
2010 were retrospectively reviewed. The criterion used to
plan oil removal was a minimum interval of 6 months
following the primary vitrectomy and a completely attached
retina without any unlasered retinal breaks. In all cases,
silicone oil removal was planned once emulsification was
noted to have begun. All patients gave a written informed
consent. All surgeries were performed by or under direct
supervision of two senior retinal surgeons (A.M. and R.R.P).
The procedure consisted of a two-port setup, and SOR was
done using a 19-G cannula on a syringe under negative
suction. After SOR, the retina was examined on table with
an endoilluminator to rule out any recurrent detachment and to
look for adequacy of endolaser. Additional laser was applied
on table as deemed necessary by making an additional scle-
rotomy port. Strict aseptic precautions were adhered to during
surgery with adequate protective gear for the surgical and
assisting team and disposal of all materials used during the
surgery to prevent any risk of HIV transmission.
The data collected from the patient’s records included the
patient’s age, gender, preoperative best-corrected visual acu-
ity, postoperative best-corrected visual acuity, the type of
anti-CMV treatment used, use of encirclage at the time of
primary detachment surgery, time interval between the ini-
tial detachment surgery and SOR, viscosity of the silicone
oil used, and whether or not SOR was combined with
cataract surgery. The outcome measure studied was the
number of eyes with attached retina following silicone oil
removal at the last follow-up. The statistical analysis was
done using the Statistical Package for Social Sciences ver-
sion 16. The preoperative and postoperative visual acuity
were compared using the paired t test. A p value of <0.05
was assigned as significant. The confidence intervals around
the percentages were calculated by the mid-P exact test.
Results
During the study period, there were 60 eyes of 55 patients who
underwent primary vitrectomywith silicone oil tamponade for
repair of CMV retinitis-related retinal detachment. Of these,
11 eyes of ten patients underwent SOR. Of the remaining
eyes, 37 eyes were lost to follow-up before 6 months, while
the remaining 12 had recurrent detachment. There were two
females and eight males, and the mean age was 41.27±
9.8 years. The duration between primary detachment surgery
and SOR was 8.82±2.56 months. The mean duration of HIV
positivity was 33±28.65 months (nearly 3 years). The average
CD4 cell count at the time of SOR was 365±85 cells/mm3.
The mean best-corrected pre-SOR visual acuity in logMAR
was 1±0.85, and the post-SOR acuity was 1.13±0.67
(p00.69). The mean preoperative intraocular pressure
(IOP) noted was 16.9±2.88 mm Hg, and the postopera-
tive IOP was 13.63±2.34 mm Hg. One eye had an
encirclage band passed before vitrectomy. Three eyes
had active CMV retinitis when detachment developed,
while the rest had healed CMV lesions. Those with
active disease were put on oral Valgancyclovir 900 mg
twice a day. The CD4 counts were recorded to monitor
the immune status. Six out of the ten patients were on
highly active antiretroviral therapy (HAART) at presentation.
The rest were examined by the internist and started on
HAART subsequently. Four eyes had 5,000 cs silicone oil
used, while seven eyes had 1,000 cs oil.
Only one eye had cataract at the time of SOR, but cataract
surgery was not performed as it was not clinically significant.
Following SOR, eight eyes underwent cataract surgery
over the next year. Though all eyes had an attached
retina immediately following SOR, redetachment occurred
in two eyes at 1 month post-SOR. One of the eyes underwent
additional endolaser with silicone oil injection. The other
eye had no light perception and was left alone. The
Table 1 Causes of poor vision
post-silicone oil removal Patient number Redetachment Optic atrophy Epiretinal membrane Corneal scar Vitritis Macular
scarring
1 − + − − − +
2 + + − − − −
3 + − − + − −
4 − − − − − −
5 − − − − − −
6 − − + − − −
7 − − − − + +
8 − + + − + +
9 − − + + − +
10 − + − − − −
11 − + − − − −
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causes of poor final visual acuityweremultifactorial (Table 1).
The mean follow-up post-SOR was 7.54±7.76 months
(range, 1–23 months; median, 5 months). Out of 11 eyes
that underwent SOR, in 9 eyes, the retina was attached at
the last follow-up. The anatomical success rate following
SOR was 81.82% (9/11; CI, 59.03–100%).
Discussion
Silicone oil is the preferred tamponade following vitrectomy
for retinal detachment surgeries associated with CMV reti-
nitis. A wide range of retinal attachment rate varying from
8–95% has been reported in the literature for these cases
with silicone oil tamponade [1, 9] With the advent of the
HAART therapy for HIV patients, the life expectancy has
increased over a period of time. Thus, an increased longev-
ity necessitates SOR in many patients who have undergone
primary vitreous surgery with silicone oil tamponade. As
there is paucity of literature on the outcomes of such eyes
following SOR, our study aimed to document the outcomes
of these eyes. A similar study conducted by Morrison et al.
[10] reported a 53% rate of redetachment after silicone oil
removal at a median period of 4 months post-SOR. Nine
eyes in their series had C3F8, SF6, or air injection at the end
of surgery. They observed that simultaneous cataract
surgery at the time of SOR and lower CD4 cell counts
were associated with a greater risk of redetachment. Our study
showed a redetachment rate of 18.2% (2/11; 95%CI, 0–41%).
The mean CD4 cell count in their study was 173 cells/mm3,
while that in our study was 365 cells/mm3. Also, none of our
patients had cataract surgery combined with the SOR at the
same sitting. The high CD4 cell count indicates a greater
immune competence and possibly could be hypothesized to
have contributed to better surgical outcome [11].
Our study has a few inherent limitations and observa-
tions. Being a retrospective study, the results need to be
interpreted with caution. As the overall sample size is small
(11 eyes) and the number of unfavorable events being still
smaller (two redetachments), to derive any statistical
inference from this study would be erroneous. The overall
follow-up is short, both after the primary surgery and after
silicone oil removal. This is possibly due to the majority of
patients belonging to the lower socioeconomic strata as well
as the high mortality associated with AIDS. Among the eyes
that did not undergo SOR, 12 eyes had recurrent detachment.
A high rate of loss of follow-up (62%) is a major limiting
factor of the present study.
In summary, among the eyes that did not undergo SOR, 12
eyes had recurrent detachment. Overall, 14 out of 23 eyes
(61%; CI, 40–79%) developed recurrent retinal detachment
on follow-up. Our series also showed a retinal attachment rate
of 82% following silicone oil removal at a mean follow-up of
7.5 months in eyes that underwent vitrectomy for CMV
retinitis-related retinal detachment. This is an improvement
on the rates that have been reported in the literature and could
be attributed to the higher CD4 counts. Thus, though the overall
redetachment rate post-vitrectomy with silicone oil is poor, in
cases with attached retina over 6 months, there is a high
attachment rate seen post-SOR. A larger prospective series with
a longer follow-up is desirous to further validate these results.
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